Julius Clinical logo

Julius Clinical

Julius Clinical manages global clinical drug trials that will have a major impact on medicine and make a real difference

176 employees · est. 2008 · Zeist, The Netherlands

VS
Molecular Partners logo

Molecular Partners

Pioneering DARPin Therapeutics for Patients

174 employees · est. 2004 · Switzerland

Molecular Partners is the older company (2008 vs 2004).

Side-by-Side Comparison

Julius Clinical Molecular Partners
Founded
2008 2004 older
Headquarters
Zeist, The Netherlands Switzerland
Employees
176 174
Industry
Health Care, Pharmaceutical Biotechnology, Pharmaceutical
Funding Stage
Private Equity Post Ipo Equity
Total Funding
Not tracked yet $179.96M
Funding Rounds
1 4
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Clinical Drug Trials, Global Reach, Scientific Approach, Clinical Development Programs, Pharmaceutical, Biotech, Medical Device, Academic Investigators, Cardiology, Diabetes, CNS, Infectious Diseases, Global Reputation Biotech, DARPin Therapeutics, Clinical-stage, Oncology, Virology, Pharmaceutical Research, Biopharmaceutical, Small Protein Therapies, Intellectual Property, Immunology, Ophthalmology, Collaborations, Serious Diseases, Top Biotech Investors
Website
juliusclinical.com molecularpartners.com
Julius Clinical logo

About Julius Clinical

Julius Clinical is a health care and pharmaceutical startup founded in 2008 and headquartered in The Netherlands. The company manages global clinical drug trials with the objective of making a significant impact on medicine and people's lives, as highlighted by their slogan, "Julius Clinical manages...

Molecular Partners logo

About Molecular Partners

Molecular Partners is a clinical-stage biotech company founded in 2004 and headquartered in Switzerland. The company specializes in pioneering DARPin therapeutics, which represent a new class of custom-built drugs aimed at addressing medical challenges that are difficult for other modalities to tack...

We will tell you when either one moves

BounceWatch watches Julius Clinical and Molecular Partners for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Julius Clinical and Molecular Partners — by email.

Frequently Asked Questions

Julius Clinical — Julius Clinical manages global clinical drug trials that will have a major impact on medicine and make a real difference. Molecular Partners — Pioneering DARPin Therapeutics for Patients. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Julius Clinical has raised undisclosed funding while Molecular Partners has raised $179.96M.
Julius Clinical and Molecular Partners operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Julius Clinical with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Julius Clinical on 12 Sep 2024, and Molecular Partners on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy